AIM ImmunoTech (AIM) Provides Update on Jorgl Activist Group Litigation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/17/2026

1. VRNS
2. JBHT
3. CRWV
4. TSLA
5. GPRK
6. SCHW
7. TRV
8. TFC
9. NVDA
10. POLYCAB:IN

Go back to AIM ImmunoTech (AIM) Provides Update on Jorgl Activist Group Litigation

AIM ImmunoTech Provides Update on Jorgl Activist Group Litigation

August 15, 2022 4:05 PM EDT

OCALA, Fla.--(BUSINESS WIRE)-- AIM ImmunoTech Inc. (NYSE: American AIM) (AIM or the Company), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, today issued the following statement regarding the outcome of a hearing in the Delaware Court of Chancery concerning a motion for a temporary restraining order (TRO) sought by activist shareholder Jonathan Jorgl:

This morning we announced in a Form 10-Q filing that on August 12, 2022, a hearing was held in the Delaware Court of Chancery concerning a motion for a temporary restraining order sought by... More